Most recent articles by:

Editorial Team

- Advertisement -

PureTech Launches New CBD Capsule to Challenge Epidiolex

PureTech Health has identified an opening to create a better alternative to Jazz Pharmaceuticals' Epidiolex. The biotech company has developed an oral...

Canon Healthcare announces new subsidiary in a bid to expand presence in the U.S.

Japanese tech giant Canon has announced the opening of its second med tech-focused subsidiary in the U.S., with the first being Canon...

Biopharma newcomer Resilience buys AstraZeneca’s Ohio facility

AstraZeneca’s Ohio facility, which was part of the United States covid vaccine production network, has new ownership. The sale...

Agreement for the commercialization of mammography AI reached between iCAD and Google Health

A deal was penned between medical tech company iCAD and Google Health to use Google’s AI technology in iCAD’s breast imaging solutions....

Hemophilia gene therapy by CSL and uniQure is now the world’s most expensive medicine

The one-time gene therapy from uniQure and CSL Behring called Hemgenix or etranacogene dezaparvovec-drlb has been approved by the FDA, making it...

Zydus Lifesciences Gets FDA Green Light For Thyroid Hormone Deficiency Drug

The United States Food and Drug Administration (USFDA) has granted Zydus Lifesciences permission to market Levothyroxine Sodium injection, a medication used to...

Study shows Apple AirPods can disrupt the market of OTC hearing aids

This year the FDA allowed the over-the-counter (OTC) sales of some hearing aids, due to which a lot of device developers have...

Novo Nordisk expands facility to increase production

Novo Nordisk will invest $744 million to expand its clinical production facilities in a Copenhagen suburb. Novo Nordisk is...

Must read

Surrounded by controversy, FDA approves Biogen’s Alzheimer’s drug Aduhelm

In the middle of the debate about the Alzheimer’s drug approval, the United States FDA has authorized Aduhelm

Amgen’s KRAS drug gets early FDA approval for lung cancer with specific mutation

On Friday, the United States FDA (Food and Drug Administration) has authorized a medication of Amgen Biopharmaceutical in patients with NSCLC
- Advertisement -